Mogi M - Search Results

1

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum.

Mogi M, Togari A, Ogawa M, Ikeguchi K, Shizuma N, Fan D, Nakano I, Nagatsu T. Mogi M, et al. Neurosci Lett. 1998 Jun 26;250(1):25-8. doi: 10.1016/s0304-3940(98)00427-3. Neurosci Lett. 1998. PMID: 9696057

2

Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction.

Mogi M, Togari A, Tanaka K, Ogawa N, Ichinose H, Nagatsu T. Mogi M, et al. Neurosci Lett. 1999 Jun 18;268(2):101-4. doi: 10.1016/s0304-3940(99)00388-2. Neurosci Lett. 1999. PMID: 10400088

3

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.

Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T. Mogi M, et al. Neurosci Lett. 1999 Jul 23;270(1):45-8. doi: 10.1016/s0304-3940(99)00463-2. Neurosci Lett. 1999. PMID: 10454142

4

Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506.

Mogi M, Togari A, Tanaka K, Ogawa N, Ichinose H, Nagatsu T. Mogi M, et al. Neurosci Lett. 2000 Aug 11;289(3):165-8. doi: 10.1016/s0304-3940(00)01275-1. Neurosci Lett. 2000. PMID: 10961655

5

Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains.

Mogi M, Togari A, Kondo T, Mizuno Y, Kogure O, Kuno S, Ichinose H, Nagatsu T. Mogi M, et al. Neurosci Lett. 2001 Mar 16;300(3):179-81. doi: 10.1016/s0304-3940(01)01577-4. Neurosci Lett. 2001. PMID: 11226640

6

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.

Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T. Mogi M, et al. Neurosci Lett. 1987 Sep 23;80(2):213-8. doi: 10.1016/0304-3940(87)90656-2. Neurosci Lett. 1987. PMID: 2891089

7

Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).

Ozaki N, Nakahara D, Mogi M, Harada M, Kiuchi K, Kaneda N, Miura Y, Kasahara Y, Nagatsu T. Ozaki N, et al. Among authors: mogi m. Neurosci Lett. 1988 Feb 29;85(2):228-32. doi: 10.1016/0304-3940(88)90356-4. Neurosci Lett. 1988. PMID: 2897647

8

p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.

Mogi M, Kondo T, Mizuno Y, Nagatsu T. Mogi M, et al. Neurosci Lett. 2007 Feb 27;414(1):94-7. doi: 10.1016/j.neulet.2006.12.003. Epub 2006 Dec 29. Neurosci Lett. 2007. PMID: 17196747

9

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients.

Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T. Mogi M, et al. Neurosci Lett. 1994 Oct 24;180(2):147-50. doi: 10.1016/0304-3940(94)90508-8. Neurosci Lett. 1994. PMID: 7700568

10

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Mogi M, et al. Neurosci Lett. 1994 Jan 3;165(1-2):208-10. doi: 10.1016/0304-3940(94)90746-3. Neurosci Lett. 1994. PMID: 8015728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters